Advertisement
Advertisement

AORT

AORT logo

Artivion, Inc.

39.57
USD
Sponsored
+0.11
+0.27%
Feb 06, 15:59 UTC -5
Closed
exchange

After-Market

40.78

+1.21
+3.06%

AORT Earnings Reports

Positive Surprise Ratio

AORT beat 27 of 39 last estimates.

69%

Next Report

Next Week
Date of Next Report
Feb 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
$118.75M
/
$0.08
Implied change from Q3 25 (Revenue/ EPS)
+6.61%
/
+33.33%
Implied change from Q4 24 (Revenue/ EPS)
+22.03%
/
-120.51%

Artivion, Inc. earnings per share and revenue

On Nov 06, 2025, AORT reported earnings of 0.06 USD per share (EPS) for Q3 25, beating the estimate of 0.01 USD, resulting in a 242.86% surprise. Revenue reached 111.39 million, compared to an expected 112.65 million, with a -1.12% difference. The market reacted with a -5.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.08 USD, with revenue projected to reach 118.75 million USD, implying an increase of 33.33% EPS, and increase of 6.61% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
logo
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
logo
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
logo
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
logo
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
For Q3 2025, Artivion, Inc. reported EPS of $0.06, beating estimates by 242.86%, and revenue of $111.39M, -1.12% below expectations.
The stock price moved down -5.54%, changed from $47.50 before the earnings release to $44.87 the day after.
The next earning report is scheduled for Feb 12, 2026.
Based on 9 analysts, Artivion, Inc. is expected to report EPS of $0.08 and revenue of $118.75M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement